Pangenotypic direct-acting antiviral combinations
WHO Essential Medicine EML section: Pangenotypic direct-acting antiviral combinations
Label status: label not available in our sources
This is information only, not a prescription. Talk to a doctor or pharmacist before taking any medicine. For an overdose or poisoning, call 102.
Daclatasvir/sofosbuvir is an essential medicine on the WHO Model List, listed under: Pangenotypic direct-acting antiviral combinations. A product label is not available in our sources.. Pangenotypic direct-acting antiviral combinations. What it is used for: Listed for: Pangenotypic direct-acting antiviral combinations (WHO EML section heading). generated by SI from cited sources · general information, not a diagnosis · consult a health professional
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
Listed for: Pangenotypic direct-acting antiviral combinations (WHO EML section heading).
For a suspected overdose or poisoning, call 102 now and go to the nearest emergency hospital.
Call 102What is Daclatasvir/sofosbuvir used for?
It is listed for: Pangenotypic direct-acting antiviral combinations (WHO Model List section).
Is Daclatasvir/sofosbuvir an essential medicine?
Yes, it is on the WHO Model List of Essential Medicines.
What is the dose of Daclatasvir/sofosbuvir?
Not provided here. Ask a doctor or pharmacist.
What is Daclatasvir/sofosbuvir?
Daclatasvir/sofosbuvir is an essential medicine on the WHO Model List, listed under: Pangenotypic direct-acting antiviral combinations. A product label is not available in our sources.
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
WHO Model List of Essential Medicines, 23rd list (2023), World Health Organization